Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? - Wikidata - wikimedia - TriplyDB

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

http://www.wikidata.org/entity/Q37233212

about

Impact of HIV Infection on Medicare Beneficiaries with Lung Cancer.Colorectal cancer screening in human immunodeficiency virus population: Are they at average risk?A case report of human immunodeficiency virus-associated anaplastic lymphoma kinase protein-negative anaplastic large cell lymphoma.Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Revisiting a role for a mammary tumor retrovirus in human breast cancer.Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden - the Greater Stockholm HIV Cohort Study.

P2860

Q35882789-C62A0ABA-07D9-41A2-A9D5-EFAF81B2E5E8 Q36637138-BED90A65-8781-44F5-8BA0-F686BE4D7B77 Q37130855-20F8E7AD-2E0D-4F3A-8C43-C2588EDF32C2 Q37131664-E5FB6530-BD60-4482-B5AB-3486162320F2 Q37416478-27F4D7CF-4648-4476-98C2-435F50E25949 Q38098480-46588498-0B48-4F5B-A15F-F88139AA83CA Q41718464-94757546-AAE4-4393-ACCE-B61A9585C82C

P2860

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

http://www.wikidata.org/entity/Q37233212

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@en

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@nl

type

label

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@en

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@nl

prefLabel

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@en

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@nl

P1433

Q37233212-A1D2E3FB-B25C-43E8-B333-C1B2F5BA7AEF

P1476

Q37233212-B418FB9D-6E1F-4AED-9F63-047861656C46

P2093

Q37233212-8103BC1B-6FEB-4DE3-8810-6C1FD32FB300

Q37233212-C2EE496D-3E0F-4466-B1AA-0A361AA18BE6

P2860

Q37233212-11DC7459-AA46-4618-800E-362B4C529A27

Q37233212-121977D4-455B-4256-A8E9-5FAFBE31A0A8

Q37233212-163B0DD7-8ACD-4B60-88E9-F1AB1AAC1CC5

Q37233212-18E43F15-AA55-41C5-94CC-D16BF0C5E3D2

Q37233212-1A26481D-FF6A-48BF-B2DF-F4255B12DB2D

Q37233212-22E29BED-0CE3-458D-A729-125CF7187263

Q37233212-22E395F7-08CB-40B0-B578-EEA6C83A9C6C

Q37233212-2533BAD5-41A6-4B6D-9A31-A74FBC5A781C

Q37233212-2ABDE84D-8F25-41D0-914C-0D0A0A6265DA

Q37233212-36A4FEC4-089E-49C3-9A63-22F483B3536C

P304

Q37233212-D61812DA-38BA-44C1-BFEC-963BA2BA8B0C

P31

Q37233212-E658E51C-B258-4B33-AC56-595A2963807C

P356

Q37233212-4D5EEF30-F473-4AF2-B2AC-0E67DB1FBD51

P433

Q37233212-C4D07300-777E-49F4-ACB0-A508459F0656

P478

Q37233212-4390230C-4D06-4EA3-9329-14A39FDFC764

P577

Q37233212-E7990BA7-E9D1-4BE7-98C8-459E085C6E05

P5875

Q37233212-6A2C33E7-682E-46EC-BC71-AFC357D63219

P698

Q37233212-693B7647-1FF3-4A9C-B694-1D27E16AFF79

P921

Q37233212-03AED75F-393D-44B1-882B-72A8E08BCAE9

Q37233212-A34B0124-CB0B-453E-B5E2-388816257E1A

P932

Q37233212-C4E3DF72-104F-418B-BE8E-6B8B4D8B94A8

P356

COH.0B013E32831A9875

P1433

Current Opinion in HIV and AIDS

P1476

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

@en

P2093

Donald I Abrams

http://www.w3.org/2001/XMLSchema#string

Michael J Silverberg

http://www.w3.org/2001/XMLSchema#string

P2860

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

Raltegravir with optimized background therapy for resistant HIV-1 infection

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.

HIV infection is associated with an increased risk for lung cancer, independent of smoking.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

AIDS across Europe, 1994-98: the EuroSIDA study.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

P304

42-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COH.0B013E32831A9875

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24251589

http://www.w3.org/2001/XMLSchema#string

P698

19339938

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2698664

http://www.w3.org/2001/XMLSchema#string